DERIVATIVES OF TETRAHYDROPYRANE AND PHARMACEUTICAL COMPOSITION Russian patent published in 1999 - IPC

Abstract RU 2130460 C1

FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to new compounds of the formula (I) where R1 means a group of the formula (1a) or (1b) where R7 means optionally substituted hydroxy-group, acyloxy-group, halogen atom, -OR10 where R10 means lower alkyl optionally substituted with -O(CH2)mOH where m is a number from 2 to 4 or -OCONH2; R7a means hydrogen atom; or R7 and R7a mean oxo-group; R8 means hydroxy- or methoxy-group and R9 means hydroxy- or acyloxy-group; R2 means hydrogen atom, acyloxy- -group or optionally substituted hydroxy-group; between two carbon atoms bound with dotted line - a simple or double bond exists; R3 means methyl, ethyl, n-propyl or allyl; or R4 means hydrogen atom or hydroxy-group and R4a means hydrogen atom; or R4 and R4a mean oxo-group; or R5 means hydroxy-group and R5a means hydrogen atom; or R5 and R5a/ mean oxo-group; A means a group of the formula -CH(OR6)-CH2-(CH2)n or -CH= CH-(CH2)n- bound with carbon atom through (CH2)n-; R6 means lower alkyl and n = 1 or 2. Compounds can be in free form or as salts. These compounds are used as pharmaceutical preparations, especially as anti-inflammatory and antiprofilerative agents. EFFECT: enhanced effectiveness of compounds as curative agents. 9 cl, 4 tbl, 36 ex

Similar patents RU2130460C1

Title Year Author Number
POLYCYCLIC MACROLACTAMS AND PHARMACEUTICAL COMPOSITION BASED ON THEM 1993
  • Karl Baumann
RU2126009C1
COMPOSITIONS CONTAINING MODULATORS OF SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR 2008
  • Colleen Ruegger
  • Michael Ambuhl
RU2779056C2
APPLICATION OF S1P RECEPTOR AGONIST AND METHOD OF TREATMENT, ALLEVIATION OR RETARDATION OF OPTIC NEURITIS OR DEMYELINATING DISEASES PROGRESSION 2003
  • Foster Karolin Ann
  • Khishtand Peter S.
  • Glu Pol Uill'Jam
RU2391094C2
PROTEINKINASE C INHIBITORS USED FOR TREATING AUTOIMMUNE DISEASES AND GRAFT REJECTION 2005
  • Vagner Jurgen
  • Shuler Val'Ter
RU2413511C2
ORGANIC COMPOUNDS 2003
  • Foster Karolin Ann
  • Khishtand Peter S.
  • Glu Pol Uill'Jam
RU2478378C2
DERIVATIVES OF PIPERIDINE AND METHOD FOR THEIR PREPARING 2001
  • Khaueh Trevor Dzhon
  • Bkhalaj Gurdip
  • Le-Grand Darren Mark
  • Shtorts Tomas
RU2278856C2
SEROTONIN ANTAGONIST (5HT3) APPLICATION METHOD FOR TREATING FIBROMYALGIA 1995
  • Mjuller Vol'Fgang
  • Shtrats Tomas
RU2165760C2
DERIVATIVES OF HYDROXAMIC ACID 1997
  • Kottirsh Georg
  • Nojmann Ul'F
RU2196131C2
8-ARYL-1,7-NAPHTHYRIDINE AND PHARMACEUTICAL COMPOSITION HAVING ANTINIFLAMMATORY ACTIVITY 1997
  • Rene Khershperger
RU2174123C2
ASCOMYCINS, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1996
  • Khersperger Rene
  • Nef Reto
RU2173688C2

RU 2 130 460 C1

Authors

Merti Bulusu

Dates

1999-05-20Published

1994-05-26Filed